Is there a link between cancer and the polio vaccine? There is a good chance that there is, according to a Baylor University study released on February 18, 1999 and published in the Journal of the National Cancer Institute. At the time, the announcement sent shockwaves throughout the medical establishment and caused a great deal of public alarm. After all, who hasn't had at least one polio shot?
But this wasn’t new knowledge. In 1987, a San Antonio physician, Dr. Eva Snead (1942-2008), stumbled across information linking vaccines to a host of diseases from AIDS and leukemia to other forms of cancer while doing research for a book on AIDS. For her efforts in trying to warn the public, she was vilified by her medical peers, ridiculed by government officials, and ignored by the major media. Even a popular radio talk host, a personal friend, was reluctant to put her on the air until the Baylor story broke.
According to sources cited by Dr. Snead, cells from the African green monkey have been used since 1953 as a growth medium for the polio vaccine. The use of the polio vaccine contaminated with green monkey virus is probably responsible for the current epidemics in child cancers, birth defects, and AIDS. These diseases, coincidentally, increased dramatically after the introduction of the polio vaccine. No one knows how many batches of this vaccine have been contaminated over the years, but exposed individuals may range in the millions. Despite assurances to the contrary, Dr. Snead insisted until her death in July 2008 that the polio and other vaccines remained contaminated with animal viruses. She coined the term Immunization Related Syndrome (IRS) for the diseases associated with these contaminated vaccines. (Coincidentally, the initials are the same as those of another well-known pathogen plaguing our society.)
Authorities in France have placed more than a third of the country under a red heat...
An influenza outbreak has reportedly sickened more than 150 recruits in training at Lackland air force...
One morning early last July, Micha Bitsinnie arrived at work to an onslaught of messages from...
